glaxo

Welcome to the 'glaxo' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'glaxo'.

Latest blogosphere posts tagged “glaxo”

• Suppression of Clinical Trials of Sumatriptan

  
  Health Care Renewal — Authority: 530
  Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsors product were suppressed. [Tfeft-Hansen  PC. Unpublished clinical trials of sumatriptan. Lancet 2009; 374: 1501-2.  Link here .] Sumatriptan, sold as Imitrex ...
  1 day ago

• Xconomy Videos: Sirtris’ Westphal and Millennium’s Dunsire Talk Cures for Ills of Big Pharma

  
  Xconomy — Authority: 710
  Big Pharma , Life Sciences , ceos Ryan McBride wrote: There’s new a dynamic at work in Big Pharma’s acquisitions of biotech companies in Boston and elsewhere. Drug companies don’t only want to buy biotech firms to enhance their R&D pipelines, they want to bring the innovators behind the biotechs ...
  2 days ago

• Treximet – head off

  
  AdPharm Blog — Authority: 146
  93" height="125" /> Click on image for original file provided by AdPharm “My migraines are so excruciating I just want to take my head off.” Treximet is superior to the ingredient in Imitrex tablets at relieving migraine pain. Brand name: Treximet Generic name/category: sumatriptan and ...
  2 days ago

• House Bill Wants Pharma To Disclose CME Funding

  
  Pharmalot — Authority: 596
  The health care reform bill passed by the House would force drugmakers to disclose how much they spend on continuing medical education classes for docs, although the Senate version doesn’t include such a requirement, according to The Wall Street Journal . The paper notes this comes as for-profit CME firms ...
  2 days ago

• FTC Eyes Supply Dispute Between Drugmakers

  
  Pharmalot — Authority: 596
  The Federal Trade Commission is concerned that some brand-name drugmakers are declining to supply some bulk ingredients to their generic rivals which, of course, want to use materials to make copies of more expensive meds, The Wall Street Journal writes. Meanwhile, GlaxoSmithKline cites a federal drug-safety ...
  2 days ago

• Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News

  
  Xconomy — Authority: 710
  Roundup , Life Sciences , FDA Rebecca Zacks wrote: Several of New England’s life sciences firms had good news to report this week. —Ryan gave a run-down of the key insights to emerge from our Xconomy Forum on pharma innovation . Sirtris CEO Christoph Westphal, for example, offered insight into one of ...
  2 days ago

• Swine flu sales: windfall or hard work?

  
  Summit Notebook — Authority: 499
  Swine flu is turning out to be a sales bonanza for drug companies - just don’t call it a windfall, says GlaxoSmithKline. As one of the world’s top suppliers of both vaccines and antiviral medicine, CEO Andrew Witty resents the implication that billions of dollars of business simply fell into his company’s lap ...
  2 days ago

• Swine flu sales: windfall or hard work?

  
  Global News Blog — Authority: 472
  Swine flu is turning out to be a sales bonanza for drug companies - just dont call it a windfall, says GlaxoSmithKline. As one of the worlds top suppliers of both vaccines and antiviral medicine, CEO Andrew Witty resents the implication that billions of dollars of business simply fell into his companys lap when the ...
  2 days ago

• Stiefel Labs Closing in New York, 260 Jobs Will be Lost

  
  EmploymentSpectator — Authority: 136
  Stiefel Labs, a maker of dermatology and skin-care products, was bought out by GlaxoSmithKline in July of this year. GSK announced on wednesday that it plans to shut down the New York laboratory and move the work from there to other domestic and international locations. The plant employs 260 people who will be out ...
  2 days ago

• Glaxo Gets FDA Approval for H1N1 (Swine) Flu Vaccine

  
  The Medical Quack — Authority: 515
  38 Million of the 250 million doses ordered by the government are available, but Glaxo said it’s approved vaccine won’t ship until next month.  This has been absolutely a fire drill to get supplied out in the US.  In the meantime, Glaxo is continuing to close facilities like some of the other manufacturers ...
  3 days ago

• Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target

  
  Xconomy — Authority: 710
  Biotech , cancer , Drugs Luke Timmerman wrote: Cambridge, MA-based Aileron Therapeutics has bet the company on the idea that it has discovered a whole new class of drugs that, like RNA interference, can hit targets in the body that are beyond the reach of conventional chemical compounds and biotech ...
  3 days ago

• Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs

  
  Xconomy — Authority: 710
  Life Sciences , Drug Development , biotechnology Ryan McBride wrote: Sanofi-Aventis (NYSE: SNY ) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an ...
  4 days ago

• Pharmalot… Pharmalittle… Morning Edition

  
  Pharmalot — Authority: 596
  Top of the morning, everyone. And a pleasant one, it is. Of course, rousting one of the short people from bed is proving challenging today - those of you with adolescents may understand. Still, we soldier on. And that calls for a cup of stimulation or two. While we brace ourselves, here are a few items to help you ...
  5 days ago

• Swine FLU A H1N1: GSK signs agreement with the WHO to donate 50 million doses of vaccine to developing countries

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 150
  GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine to WHO for distribution to developing countries most in need. GSK is working with WHO and health authorities to prepare for ...
  5 days ago

• Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters

  
  Xconomy — Authority: 710
  Biotech , vaccines , startups Luke Timmerman wrote: Kineta, the Seattle-based developer of drugs for autoimmune diseases , has won about half of a $13 million federal contract awarded to the University of Washington to create new compounds which might be used to boost the effectiveness of vaccines ...
  5 days ago

• 
  NYT > Theater — Authority: 913
  
  5 days ago

• Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill

  
  Xconomy — Authority: 710
  Biotech , deals , HIV Luke Timmerman wrote: Concert Pharmaceuticals, the Lexington, MA-based company that chemically modifies existing drugs to make them more attractive, has started human testing of an HIV medication which it hopes will help GlaxoSmithKline wrestle back market share it has been losing ...
  6 days ago

• The Trouble with Transparency

  
  PharmExec Blog — Authority: 488
  Jacky Law Guest blog by Jacky Law A couple of weeks ago I attended an industry awards dinner and had an interesting conversation with an eminent doctor who shall remain nameless. The doctor in question works in a highly specialized area and frequently talks about her research at conferences around the world. ...
  1 week ago

• Pharmalot… Pharmalittle… The Weekend Nears

  
  Pharmalot — Authority: 596
  After a long and busy week, a little downtime is in order. What will you be doing this weekend? The pumpkin patches are likely empty, so perhaps raking leaves is the thing to do - the exercise can’t hurt and leaf blowers, after all, are noisy. Or perhaps a long walk with the dog? Maybe toss a football? Our agenda ...
  1 week ago

• Pneumococcal disease: World Health Organization Grants Prequalification for Global Use to GSK’s Vaccine

  
  SALUTE DOMANI ? IL PORTALE DEL BENESSERE — Authority: 150
  The World Health Organization (WHO) has awarded prequalification for global use to Synflorix™ , GlaxoSmithKline Biologicals’ pneumococcal conjugate vaccine. The prequalification is the first for a vaccine against pneumococcal disease, which is a life-threatening disease affecting many children under five in ...
  1 week ago

Comments about glaxo